$ATEC

5 Best Healthcare Stocks to Buy for the Long Term

This article identifies five top healthcare stocks suitable for long-term investment, withAlphatec Holdings, Inc. (NASDAQ: ATEC) being the first discussed. It highlights Alphatec's recent Q1 2026 results, showing surgical and total revenue growth but notes rating adjustments by analysts due to an unexpected miss in its EOS business. Despite some challenges, the company's core surgical business performed well, and it continues to be recommended for its spinal fusion technology products.

Original reporting
Insider Monkey · Noor Ul Ain Rehman
Published May 10, 2026, 10:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 10, 2026, 11:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
5 Best Healthcare Stocks to Buy for the Long Term — source image
Decision brief

The 30-second read

$ATECNeutralMed
01

Why it matters

While revenue growth is promising, analyst rating adjustments indicate some investor caution, which could lead to short-term volatility.

02

Market read

The news is moderately relevant for healthcare investors, especially those focused on surgical devices and spinal technologies.

03

What to watch

Potential delays in product launches or regulatory approvals could impact future performance; macroeconomic factors affecting healthcare spending.

Timing: short to medium term (next 1-6 months)

Background

The article provides a positive outlook on ATEC based on recent quarterly results, emphasizing its core surgical business.

Company-level read

Ticker impact

$ATECNeutralMedium confidence
Context

The article discusses Alphatec Holdings, Inc. (NASDAQ: ATEC), highlighting recent quarterly results and analyst ratings.

Expected impact

Moderate upward price movement over the next 3-6 months, contingent on continued surgical segment performance.

Evidence & confidence

The company's core surgical business remains robust, but recent analyst downgrades due to EOS segment underperformance introduce some uncertainty. Technical indicators are currently neutral, with support levels around recent lows and resistance near all-time highs.

Market effects

Positive sentiment for the spinal fusion and surgical device sectors, with potential spillover to related life sciences stocks.

Limited regional impact; primarily US-focused company with global operations.

Moderate; sector trends in medical devices and surgical technologies influence global markets.

Counterpoint

The recent analyst downgrades may signal underlying risks not fully captured in current valuations, suggesting a more cautious approach.

Key entities

  • Alphatec Holdings, Inc.

    A medical device company specializing in spinal fusion technology.

Related articles

$ATECMed

Alphatec Holdings, Inc. Q2 2026 Earnings Call Summary

Alphatec Holdings (ATEC) reported Q2 2026 results driven by 24% growth in new surgeon adoption and 20% procedural volume growth, lifting revenue 15%. Management kept full-year surgical revenue guidance at $805M and raised adjusted EBITDA guidance to $140M. It expects Q3 free cash flow of $4M to $6M and cites margin gains from inventory and supply chain efficiency.

$ATECMed

Alphatec Holdings, Inc. (ATEC): Results of Operations and Financial Condition

Alphatec Holdings, Inc. (ATEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atec-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 ATEC Reports Second Quarter Financial Results Total revenue of $214 million, up 15% year-over-year Surgical revenue of $196 million increased 17%, driven by 20% case volume growth Company reaffirms 2026 revenue outlook CARLSB

$ATECMedAI 8/10

Here is Why Alphatec (ATEC) is One of the Best Cheap Stocks Under $10 to Buy in June

Alphatec Holdings (ATEC) reported Q1 2026 results on May 5, with total revenue up 14% to $192 million and surgical revenue up 17%. The company posted non-GAAP adjusted EBITDA of $21 million and said a new bank facility would cut annual interest expense by over $6 million and extend maturities to 2031. For 2026, it expects revenue of about $882 million and adjusted EBITDA of about $134 million.

$ATECMed

Alphatec Holdings, Inc. (ATEC): 12 Best Future Stocks to Buy Right Now.

Alphatec Holdings (ATEC) saw two analyst price-target cuts on May 7 while ratings stayed Overweight. Barclays lowered its target to $24 from $27, citing confidence in long-term growth despite near-term operational issues. Piper Sandler cut its target to $14 from $25 after first-quarter results missed expectations due to a weak EOS quarter and softer revenue per case from product mix headwinds.

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.